Northrop Grumman Corp. 10-Q Summary: Q2 2025
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Northrop Grumman Corporation is a leading global aerospace and defense technology company. Key business developments during the period include the completion of the divestiture of the Immersive Mission Solutions (IMS) training services business on May 24, 2025, for $333 million in cash. The company operates four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems.
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Total Sales | $10,351 million | $10,218 million | $19,819 million | $20,351 million |
| Operating Income | $1,425 million | $1,090 million | $1,998 million | $2,161 million |
| Operating Margin | 13.8% | 10.7% | 10.1% | 10.6% |
| Net Earnings | $1,174 million | $940 million | $1,655 million | $1,884 million |
| Diluted EPS | $8.15 | $6.36 | $11.45 | $12.69 |
| Cash & Equivalents | $1,899 million | (As of June 30, 2025) | ||
| Long-Term Debt | $15,160 million | (As of June 30, 2025) | ||
| Backlog | $89.7 billion | (As of June 30, 2025) |
Material Changes vs. Prior Period
- Divestiture Impact: The sale of the training services business generated a pre-tax gain of $231 million in Q2 2025, significantly boosting operating income and net earnings for the quarter.
- B-21 Program Loss: In Q1 2025, the company recognized an additional $477 million loss provision on the B-21 Low-Rate Initial Production (LRIP) options. This negatively impacted year-to-date operating income and margins, particularly within the Aeronautics Systems segment.
- Segment Performance:
- Mission Systems: Sales increased 14% in Q2 and 10% YTD, driven by restricted award timing and higher volume on marine systems and radar programs.
- Defense Systems: Sales increased 7% in Q2 and 6% YTD, driven by the Sentinel program and military ammunition.
- Space Systems: Sales decreased 12% in Q2 and 15% YTD due to the wind-down of work on restricted space and Next Generation Interceptor (NGI) programs.
- Cash Flow: Net cash used in operating activities was $697 million YTD 2025, compared to $719 million provided in YTD 2024. This shift was primarily due to higher net cash taxes and increased trade working capital.
Guidance, Outlook, and Risks
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) enacted on July 4, 2025, is expected to increase the 2025 effective tax rate to the high 17% range but provide a cash tax benefit of $200–$250 million.
- B-21 Outlook: The company is in discussions with the U.S. Air Force regarding an accelerated production rate. While this could improve returns, it may require future investment to expand capacity. The remaining loss accrual on the B-21 program is $1.6 billion.
- Sentinel Program: Following a Nunn-McCurdy breach review, the program was certified for continuation and is being restructured. A $76 million favorable EAC adjustment was recorded in Q2 2025 related to expected contract incentives.
- Capital Allocation: The company increased its quarterly dividend to $2.31 per share. As of June 30, 2025, $3.3 billion remained in share repurchase authorization.
- Risks: Key risks include dependence on U.S. government funding, potential delays in appropriations, supply chain disruptions, and ongoing investigations regarding CAS pension expense interest rate assumptions.
Investor Verification Checklist
- B-21 Loss Provision: Verify the remaining $1.6 billion loss accrual and the status of negotiations regarding accelerated production rates and cost recovery.
- Divestiture Proceeds: Confirm the final working capital adjustment on the $333 million sale of the training services business.
- Tax Rate Impact: Monitor the implementation of the OBBBA and its effect on the effective tax rate and cash tax payments in Q3 2025.
- Working Capital Trends: Review the $2.99 billion increase in trade working capital usage YTD 2025 to understand the timing of collections and billings.
- Legal Proceedings: Track the outcome of the DOJ and DCMA investigations regarding CAS pension expense interest rate assumptions.